An Evaluation of the Initiation and Use of Sacubitril/Valsartan in an Inpatient Heart Failure Population: A Retrospective Medication Use Evaluation
Enregistré dans:
| Auteurs principaux: | Tara Snyder, Krissy-Ann Thornby, Amy Henneman, Robert Thornby |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
California Pharmacists Association
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4c0713ef4a464a198358a531163db999 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Renal protective effect of sacubitril/valsartan in patients with heart failure
par: Hui-Ling Hsieh, et autres
Publié: (2021) -
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
par: Cuthbert JJ, et autres
Publié: (2020) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
par: Mauro Gori, et autres
Publié: (2021) -
Sacubitril/valsartan in real-life clinical practice
par: Yüksel Çavuşoğlu
Publié: (2021) -
Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red
par: Kateryna Peleshok, et autres
Publié: (2021)